Aurigene to Invest in Curis at Premium Through Waiver of Certain Milestone Payments Under Collaboration Agreement

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. META
4. MU
5. ACN
6. NVDA
7. IBM
8. PRIM
9. SPY
10. PFE

Go back to Aurigene to Invest in Curis at Premium Through Waiver of Certain Milestone Payments Under Collaboration Agreement

Baird Reiterates Outperform on Curis (CRIS) as Aurigene Forgoes Milestone Payments; Increases Equity Position

September 7, 2016 9:40 AM EDT

Baird reiterated an Outperform rating and $7.00 price target on Curis (NASDAQ: CRIS) following the company's announcement that Aurigene has agreed to increase their equity position in Curis. In exchange for 10.2M shares of Curis common stock, Aurigene is giving up the rights to... More